All treatments
Treatment
Lenacapavir Injection clinical trials
2 indexed studies · 0 currently recruiting
- Active not recruitingPHASE2
Study of Lenacapavir Taken Twice a Year for HIV Pre-Exposure Prophylaxis (PrEP)
This study looks at a new drug, lenacapavir, given as an injection twice a year, and a daily tablet, F/TDF (Truvada), to prevent HIV. It compares how well they work, their safety, and how easy they are to use for people at higher risk of getting HIV.
For: Pre-Exposure Prophylaxis of HIV InfectionFrance · United Kingdom - Active not recruitingPHASE2
A Study of Teropavimab and Zinlirvimab in Combination With Capsid Inhibitor Lenacapavir in Virologically Suppressed Adults With HIV-1 Infection
This study is testing new medicines (teropavimab, zinlirvimab, and lenacapavir) for people with HIV-1 whose virus is already under control. It compares these new drugs to their usual medication to see if they are safe and work well.
For: HIV-1 InfectionUnited States · Australia · Canada